Johnson & Johnson Medical Devices Companies announced its acquisition of Orthotaxy, a privately held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution.
The technology is in early-stage development for total and partial knee replacement, and Johnson & Johnson Medical Devices Companies plan to broaden its application for a range of orthopedic surgery procedures, according to a company press release. With the goal to build a next-generation robotic-assisted orthopedic surgery solution that is cost-effective, time-efficient and user-friendly in a variety of care settings, Orthotaxy’s technology will reportedly be a critical part of a complete orthopedic solution that uses enabling technologies to personalize procedures, optimize surgery and bring value to customers and patients.
The release also noted Johnson & Johnson Medical Devices Companies plan to focus on digital technology solutions that expand beyond providing best-in-class products to transformative solutions across the full continuum of care in the future.
“Our goal is to bring to market a robotic-assisted surgery technology that is an integral part of a comprehensive orthopedics platform, delivering value to patients, physicians and health care providers across the episode of care,” Ciro Römer, company group chairman of DePuy Synthes, the orthopedics business of Johnson & Johnson, said in the release. “The team at Orthotaxy has significant expertise and passion in developing this platform, and we aspire to bring to market a differentiated technology that helps improve clinical outcomes and increases patient satisfaction.”